In a study by Cui et al., an analysis of 496 PCa patients from The Cancer Genome Atlas (TCGA) database revealed a correlation between increased AKR1C3 expression and advanced disease stages, as indicated by high T stage, N stage, and Gleason score values. This evidence concerns the gene AKR1C3 and posterior cortical atrophy.